Please login to the form below
United Drug
This page shows the latest United Drug news and features for those working in and with pharma, biotech and healthcare.
The Holy Grail of healthcare pricing
This is important because now politicians, patients and advocacy groups have reached an important milestone in the fight for lower drug pricing in the United States with the signing of the ... No drug with an orphan designation or less than $200m in
Latest news
-
Pfizer snaps up Biohaven’s migraine drug for $1.24bn
Pfizer will sell the migraine drug outside the US and will also gain the rights to a second drug. ... Neuroscience specialist Biohaven Pharmaceuticals has teamed up with Pfizer to commercialise its recently launched migraine drug Nurtec ODT (rimegepant)
-
AZ buys Caelum Biosciences for $500m
CAEL-101 has been given orphan drug status in both the United States and European Union and, in June, was granted fast track designation by the FDA.
-
J&J halts manufacturing of COVID-19 at US plant after FDA warning
Johnson &Johnson (J&J) has halted manufacturing of its COVID-19 vaccine at a plant in the US after the Food and Drug Administration (FDA) identified ‘ certain conditions’ that could lead ... comprehensively”. “The company will also continue to
-
White House unveils plans to reimport medicines from Canada
However, this is a tactic, not a policy solution. It is a work-around that will not solve the underlying prescription drug cost problem in the United States – massive market failure ... stemming from unregulated monopolistic pricing by drug companies
-
Trump attempts The Art of the Deal with pharma
The President of the United States recently unveiled his long-awaited plan to lower prescription drug prices in America.Trump’s plan, called American Patients First, The Trump Administration Blueprint to ... In the United States, drug companies are
More from news
Approximately 1 fully matching, plus 24 partially matching documents found.
Latest Intelligence
-
Adopting a holistic approach in crafting a product’s value story: utilising HEOR and RWE throughout the product life cycle
By Gary Schneider, Koen Degeling and Kathy Belk. A recent analysis revealed that among drug launches in the United States between 2012 and 2017, a total of 36% failed to meet ... Likewise, many previously developed RWD algorithms will carry over to
-
Applying real-world evidence to orphan drugs
These include the United States 1983 Orphan Drug Act, which offers tax incentives, the Food and Drug Administration (FDA) Office of Orphan Products (OOPD) which promotes collaboration between multiple stakeholders by
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Why aren't doctors using digital therapeutics?
Across the Atlantic, the United States Food and Drug Administration (FDA) is also currently still in the pilot stage of its Software Precertification Program, which is redefining how the FDA regulates ... London. EC1A 4HY. United Kingdom.
-
Indians scalp cowboys in patent war
An unlikely treaty between global pharma and native Americans. In the United States, the drug company Allergan has found an ingenious solution to the patent expiry issue. ... In America, tribal reservations are often dispiriting places, with high levels
-
Part Two: The First Amendment: Physician education using off-label indications to ensure that patients receive the most effective treatment.
The body of law that regulates the marketing of medical device products in the United States is the Drug and Cosmetic Act, which places a restriction on off-label marketing and
-
MSL Corporate Strategy and Growth (Part One)
There are several bodies of law that regulate the MSL environment in the United States and one is the Drug and Cosmetic Act, which places a restriction on off-label marketing ... The Author of this work is Jennifer Williams and titled: MSL Corporate
-
Watermeadow Medical
Watermeadow is part of Ashfield Healthcare Communications (a United Drug company), giving our clients access to over 1100 medical communications specialists including extensive digital teams and offices around the globe.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- The state of pharma customer experience
- GSK and CureVac to advance mRNA COVID-19 and flu vaccine candidates
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
